Selected research
Market Structure
Global cfDNA Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global cfDNA Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for cfDNA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of cfDNA Testing include Illumina, Oncogenomics, Revvity, CareDx, Natera, BillionToOne, Inc., Yourgene Health, ARUP Laboratories and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global cfDNA Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of cfDNA Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents cfDNA Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the cfDNA Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
cfDNA Testing Segment by Company
Illumina
Oncogenomics
Revvity
CareDx
Natera
BillionToOne, Inc.
Yourgene Health
ARUP Laboratories
Roche
cfDNA Testing Segment by Type
Targeted Sequencing
Whole Genome Sequencing
cfDNA Testing Segment by Application
Prenatal Testing
Oncology
Organ Transplant Monitoring
Others
cfDNA Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global cfDNA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of cfDNA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of cfDNA Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of cfDNA Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global cfDNA Testing industry.
Chapter 3: Detailed analysis of cfDNA Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, cfDNA Testingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing
- Whole Genome Sequencing
Applications
- Prenatal Testing
- Oncology
- Organ Transplant Monitoring
- Others
Companies covered
- Illumina
- Oncogenomics
- Revvity
- CareDx
- Natera
- BillionToOne, Inc.
- Yourgene Health
- ARUP Laboratories
- Roche
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global cfDNA Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Targeted Sequencing
- 1.2.3 Whole Genome Sequencing
- 1.3 Market Analysis by Application
- 1.3.1 Global cfDNA Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Prenatal Testing
- 1.3.3 Oncology
- 1.3.4 Organ Transplant Monitoring
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global cfDNA Testing Growth Trends by Region
- 1.5.1 Global cfDNA Testing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 cfDNA Testing Market Size by Region (2021-2026)
- 1.5.3 cfDNA Testing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global cfDNA Testing Market Dynamics
- 2.1 cfDNA Testing Industry Trends
- 2.2 cfDNA Testing Industry Drivers
- 2.3 cfDNA Testing Industry Opportunities and Challenges
- 2.4 cfDNA Testing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global cfDNA Testing Revenue by Company (2021-2026)
- 3.2 Global cfDNA Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global cfDNA Testing Key Company Head office and Area Served
- 3.4 Global cfDNA Testing Company, Product Type & Application
- 3.5 Global cfDNA Testing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global cfDNA Testing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 cfDNA Testing Players Market Share by Revenue in 2025
- 3.6.3 2025 cfDNA Testing Tier 1, Tier 2, and Tier 3
4 cfDNA Testing Market by Type
- 4.1 Global cfDNA Testing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global cfDNA Testing Market Size by Type (2021-2032)
- 4.3 Global cfDNA Testing Market Size Share by Type (2021-2032)
5 cfDNA Testing Market by Application
- 5.1 Global cfDNA Testing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global cfDNA Testing Market Size by Application (2021-2032)
- 5.3 Global cfDNA Testing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Illumina cfDNA Testing Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 Oncogenomics
- 6.2.1 Oncogenomics Company Information
- 6.2.2 Oncogenomics Business Overview
- 6.2.3 Oncogenomics cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Oncogenomics cfDNA Testing Product Portfolio
- 6.2.5 Oncogenomics Recent Developments
- 6.3 Revvity
- 6.3.1 Revvity Company Information
- 6.3.2 Revvity Business Overview
- 6.3.3 Revvity cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Revvity cfDNA Testing Product Portfolio
- 6.3.5 Revvity Recent Developments
- 6.4 CareDx
- 6.4.1 CareDx Company Information
- 6.4.2 CareDx Business Overview
- 6.4.3 CareDx cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 CareDx cfDNA Testing Product Portfolio
- 6.4.5 CareDx Recent Developments
- 6.5 Natera
- 6.5.1 Natera Company Information
- 6.5.2 Natera Business Overview
- 6.5.3 Natera cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Natera cfDNA Testing Product Portfolio
- 6.5.5 Natera Recent Developments
- 6.6 BillionToOne, Inc.
- 6.6.1 BillionToOne, Inc. Company Information
- 6.6.2 BillionToOne, Inc. Business Overview
- 6.6.3 BillionToOne, Inc. cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 BillionToOne, Inc. cfDNA Testing Product Portfolio
- 6.6.5 BillionToOne, Inc. Recent Developments
- 6.7 Yourgene Health
- 6.7.1 Yourgene Health Company Information
- 6.7.2 Yourgene Health Business Overview
- 6.7.3 Yourgene Health cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Yourgene Health cfDNA Testing Product Portfolio
- 6.7.5 Yourgene Health Recent Developments
- 6.8 ARUP Laboratories
- 6.8.1 ARUP Laboratories Company Information
- 6.8.2 ARUP Laboratories Business Overview
- 6.8.3 ARUP Laboratories cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 ARUP Laboratories cfDNA Testing Product Portfolio
- 6.8.5 ARUP Laboratories Recent Developments
- 6.9 Roche
- 6.9.1 Roche Company Information
- 6.9.2 Roche Business Overview
- 6.9.3 Roche cfDNA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Roche cfDNA Testing Product Portfolio
- 6.9.5 Roche Recent Developments
7 North America
- 7.1 North America cfDNA Testing Market Size (2021-2032)
- 7.2 North America cfDNA Testing Market Size by Type
- 7.2.1 North America cfDNA Testing Market Size by Type (2021-2026)
- 7.2.2 North America cfDNA Testing Market Size by Type (2027-2032)
- 7.2.3 North America cfDNA Testing Market Share by Type (2021-2032)
- 7.3 North America cfDNA Testing Market Size by Application
- 7.3.1 North America cfDNA Testing Market Size by Application (2021-2026)
- 7.3.2 North America cfDNA Testing Market Size by Application (2027-2032)
- 7.3.3 North America cfDNA Testing Market Share by Application (2021-2032)
- 7.4 North America cfDNA Testing Market Size by Country
- 7.4.1 North America cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America cfDNA Testing Market Size by Country (2021-2026)
- 7.4.3 North America cfDNA Testing Market Size by Country (2027-2032)
- 7.4.4 North America cfDNA Testing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe cfDNA Testing Market Size (2021-2032)
- 8.2 Europe cfDNA Testing Market Size by Type
- 8.2.1 Europe cfDNA Testing Market Size by Type (2021-2026)
- 8.2.2 Europe cfDNA Testing Market Size by Type (2027-2032)
- 8.2.3 Europe cfDNA Testing Market Share by Type (2021-2032)
- 8.3 Europe cfDNA Testing Market Size by Application
- 8.3.1 Europe cfDNA Testing Market Size by Application (2021-2026)
- 8.3.2 Europe cfDNA Testing Market Size by Application (2027-2032)
- 8.3.3 Europe cfDNA Testing Market Share by Application (2021-2032)
- 8.4 Europe cfDNA Testing Market Size by Country
- 8.4.1 Europe cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe cfDNA Testing Market Size by Country (2021-2026)
- 8.4.3 Europe cfDNA Testing Market Size by Country (2027-2032)
- 8.4.4 Europe cfDNA Testing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China cfDNA Testing Market Size (2021-2032)
- 9.2 China cfDNA Testing Market Size by Type
- 9.2.1 China cfDNA Testing Market Size by Type (2021-2026)
- 9.2.2 China cfDNA Testing Market Size by Type (2027-2032)
- 9.2.3 China cfDNA Testing Market Share by Type (2021-2032)
- 9.3 China cfDNA Testing Market Size by Application
- 9.3.1 China cfDNA Testing Market Size by Application (2021-2026)
- 9.3.2 China cfDNA Testing Market Size by Application (2027-2032)
- 9.3.3 China cfDNA Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia cfDNA Testing Market Size (2021-2032)
- 10.2 Asia cfDNA Testing Market Size by Type
- 10.2.1 Asia cfDNA Testing Market Size by Type (2021-2026)
- 10.2.2 Asia cfDNA Testing Market Size by Type (2027-2032)
- 10.2.3 Asia cfDNA Testing Market Share by Type (2021-2032)
- 10.3 Asia cfDNA Testing Market Size by Application
- 10.3.1 Asia cfDNA Testing Market Size by Application (2021-2026)
- 10.3.2 Asia cfDNA Testing Market Size by Application (2027-2032)
- 10.3.3 Asia cfDNA Testing Market Share by Application (2021-2032)
- 10.4 Asia cfDNA Testing Market Size by Country
- 10.4.1 Asia cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia cfDNA Testing Market Size by Country (2021-2026)
- 10.4.3 Asia cfDNA Testing Market Size by Country (2027-2032)
- 10.4.4 Asia cfDNA Testing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa cfDNA Testing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa cfDNA Testing Market Size by Type
- 11.2.1 South America, Middle East & Africa cfDNA Testing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa cfDNA Testing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa cfDNA Testing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa cfDNA Testing Market Size by Application
- 11.3.1 South America, Middle East & Africa cfDNA Testing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa cfDNA Testing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa cfDNA Testing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa cfDNA Testing Market Size by Country
- 11.4.1 South America, Middle East & Africa cfDNA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa cfDNA Testing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa cfDNA Testing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa cfDNA Testing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst